These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3296670)

  • 1. Insulin and C-peptide secretory responses to glucagon in man: studies on the dose-response relationships.
    Ahrén B; Nobin A; Scherstén B
    Acta Med Scand; 1987; 221(2):185-90. PubMed ID: 3296670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
    Kruszynska YT; Goulas S; Wollen N; McIntyre N
    J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin/C-peptide response to intravenous glucagon. A dose-response study in normal and non-insulin-dependent diabetic subjects.
    Snorgaard O; Hasselstrøm K; Lumholtz IB; Thorsteinsson B; Siersbaek-Nielsen K
    Acta Endocrinol (Copenh); 1988 Jan; 117(1):109-15. PubMed ID: 3289292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
    Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
    Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion.
    Pørksen N; Grøfte B; Nyholm B; Holst JJ; Pincus SM; Veldhuis JD; Schmitz O; Butler PC
    Diabetes; 1998 Jan; 47(1):45-9. PubMed ID: 9421373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oscillations in insulin secretion during constant glucose infusion in normal man: relationship to changes in plasma glucose.
    Shapiro ET; Tillil H; Polonsky KS; Fang VS; Rubenstein AH; Van Cauter E
    J Clin Endocrinol Metab; 1988 Aug; 67(2):307-14. PubMed ID: 3292558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes.
    Ahrén B; Lundquist I; Scherstén B
    Diabetes Res; 1986 Jul; 3(6):293-300. PubMed ID: 3530592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T; Ohneda A; Nihei J; Kobayashi T
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose tolerance and insulin and C-peptide responses after various insulin secretory stimuli in hyper- and hypothyroid subjects before and after treatment.
    Ahrén B; Lundquist I; Hedner P; Valdemarsson S; Scherstén B
    Diabetes Res; 1985 Mar; 2(2):95-103. PubMed ID: 2412749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta 2-adrenoceptor induced increase of plasma insulin levels in man: evidence of direct and indirect B-cell stimulation and liver effects.
    Ahrén B; Scherstén B
    Diabetes Res; 1986 Nov; 3(9):443-5. PubMed ID: 3030608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis.
    Kruszynska YT; Ghatei MA; Bloom SR; McIntyre N
    Hepatology; 1995 Apr; 21(4):933-41. PubMed ID: 7705803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin and C-peptide in ascitic fluid and plasma and their relative responses to glucagon in patients with cirrhosis.
    Akgün S; Samanta A; Ertel NH
    J Endocrinol Invest; 1988 Dec; 11(11):789-93. PubMed ID: 3066813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.
    Gutniak MK; Linde B; Holst JJ; Efendić S
    Diabetes Care; 1994 Sep; 17(9):1039-44. PubMed ID: 7988303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus.
    Gjessing HJ; Reinholdt B; Faber OK; Pedersen O
    Acta Endocrinol (Copenh); 1991 May; 124(5):556-62. PubMed ID: 2028714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.
    Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
    Scand J Clin Lab Invest; 2007; 67(3):327-36. PubMed ID: 17454847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon increases insulin levels by stimulating insulin secretion without effect on insulin clearance in mice.
    Song G; Pacini G; Ahrén B; D'Argenio DZ
    Peptides; 2017 Feb; 88():74-79. PubMed ID: 28012858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
    Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
    Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclosporin on insulin and C-peptide secretion in healthy beagles.
    Alejandro R; Feldman EC; Bloom AD; Kenyon NS
    Diabetes; 1989 Jun; 38(6):698-703. PubMed ID: 2656339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
    Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA
    Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.